One sentence summary: We summarize studies of calcineurin signaling and hyphal growth, virulence and drug tolerance in Candida species, focusing on the divergent and conserved functions. Editor: Richard Calderone
INTRODUCTION
The term 'calcineurin' was first coined by Klee, Crouch and Krinks (1979) based on the calcium-binding properties and localization of this novel enzyme to nervous tissue. Calcineurin, a promising target for antifungal drug development, is a calcium/ calmodulin-dependent serine/threonine-specific protein phosphatase. Calcineurin is comprised of a catalytic subunit A (Cna1) and a regulatory B subunit (Cnb1) in most fungi, except in the zygomycete Mucor circinelloides in which calcineurin has three catalytic subunits (CnaA, CnaB and CnaC) (Lee et al. 2013) and in Saccharomyces cerevisiae in which it has two catalytic subunits (Cmp1 and Cmp2) (Liu et al. 1991) . Upon stimulation of calcium from extracellular or intracellular sources, calmodulin associates with the calcineurin AB heterodimer, stimulating phosphatase activity by dislodging the autoinhibitory domain of calcineurin A and dephosphorylating the downstream targets, such as the transcription factor Crz1 (in fungi) or the nuclear factor of activated T cells (NFAT in mammals). Dephosphorylated Crz1 or NFAT then migrates into the nucleus and regulates gene expression (Steinbach et al. 2007; Juvvadi, Lamoth and Steinbach 2014) . Notably, active calcineurin is always an AB heterodimer, and the loss of Cnb1 often results in destabilization of the Cna1 catalytic subunit (Chen et al. 2010) . In addition to the well-known Crz1 target, several other calcineurin substrates have been identified in baker's yeast such as proteins involved in calcium homeostasis, sphingolipid biosynthesis and protein trafficking (Cyert and Philpott 2013) . Recently, Goldman et al. identified 15 novel calcineurin substrates using phosphoproteomics and bioinformatics. These substrates are involved in membrane structure, Figure 1 . Calcineurin signaling pathway in S. cerevisiae, C. albicans, Cr. neoformans and A. fumigatus. Calcineurin is comprised of a catalytic subunit (Cna1) and a regulatory subunit (Cnb1), and can be activated by calcium/calmodulin (Cam1) in response to calcium fluxes from the environment via the Cch1/Mid1 channel or intracellular sources. Activated calcineurin dephosphorylates its downstream substrates (25 in S. cerevisiae, and 1 each in C. albicans, Cr. neoformans and A. fumigatus). The transcription factor Crz1 is a well-known calcineurin substrate in fungi. When Crz1 is dephosphorylated, it can trigger nuclear translocation of Crz1 and regulates the expression of various genes. The phenotypes or functions affected by calcineurin and its substrates are shown.
glucose-sensing, cell wall integrity, pheromone response, polarized growth, cell cycle, ubiquitin signaling and autophagy, suggesting that calcineurin affects various growth machineries of baker's yeast (Goldman et al. 2014) (Fig. 1) . To date, the only common substrate of calcineurin, Rcn1/RCAN1, has been found in fungi and mammals, indicating divergent substrates of calcineurin (Fuentes et al. 1995; Kingsbury and Cunningham 2000; Cyert and Philpott 2013) .
The divergent functions of orthologous proteins in baker's yeast and C. albicans or non-albicans Candida species (NACS) have been extensively studied (Bethea et al. 2010; Ding et al. 2011; Turner and Butler 2014) . For instance, C. albicans Gal4 ortholog activates the gluconeogenesis LAT1 gene in contrast to galactose metabolism genes such as GAL10 that were activated by S. cerevisiae Gal4. Interestingly, CaGAL10 was activated by another transcription factor Cph1 (Martchenko, Levitin and Whiteway 2007; . Although the functions of the structural gene ScINO1 (required for inositol biosynthesis) are conserved in S. cerevisiae, C. glabrata and C. albicans, the function of Opi1, a negative regulator of INO1, is different. The expression of INO1 of S. cerevisiae and C. glabrata is regulated by Opi1 and exogenously provided inositol (White, Hirsch and Henry 1991;  Bethea et al. 2010 ), but similar regulation or phenomena were not found in C. albicans (Chen et al. 2015) . Meanwhile, in contrast to S. cerevisiae, the C. albicans heterodimeric transcription factors Ino2 and Ino4 did not activate INO1 expression, but instead regulated ribosomal protein gene RPL32 (Hoppen et al. 2007) . Previous studies found that C. glabrata calcineurin mutants (cna1 and cnb1) exhibited temperature sensitivity , which is in contrast to other Candida species (Chen et al. , 2015 , indicating that calcineurin function might be different among Candida species.In addition, the calcineurin downstream target Crz1 exhibited varying functions in terms of drug tolerance across Candida species (Table 1; Fig. 2 ), suggesting the divergent function of Crz1. Further investigations of the mechanisms will thus be needed.
In this article, we discuss the conserved and divergent functions of calcineurin signaling in morphogenesis, virulence and drug tolerance as identified according to recent studies in Candida species C. albicans, C. dubliniensis, C. tropicalis, C. lusitaniae and C. glabrata. Based on analyses and comparisons, we reveal evolutionary conservation and divergence in calcineurin signaling cascades in Candida species.
Requirement of calcineurin for hyphal growth in Candida species
The requirement of calcineurin signaling in hyphal growth varies according to Candida species. In C. albicans, the role of calcineurin in hyphal development is controversial. One group demonstrated that calcineurin is essential for hyphal growth on Spider medium (carbon source starvation) (Sanglard et al. 2003) , whereas two other groups found no clear role for calcineurin in controlling hyphal growth (Blankenship et al. 2003; Bader et al. 2006 ). These contrasting findings can possibly be attributed to different C. albicans backgrounds or experimental procedures. The above studies inspired us to investigate the roles of the calcineurin pathway in hyphal or pseudohyphal growth in NACS including C. dubliniensis, C. tropicalis, C. lusitaniae and C. glabrata. We found that calcineurin is necessary for hyphal (C. dubliniensis and C. tropicalis) and pseudohyphal (C. lusitaniae) growth (Chen et al. , 2014 Zhang, Heitman and Chen 2012; (Table 1; Figs 2 and 3) . Although the roles of calcineurin signaling in pseudohyphal growth of C. glabrata have not been tested, Chen et al. demonstrated its role in plasma membrane integrity as evidenced by transmission electron microscopy. Candida glabrata has an intact plasma membrane, while cna1, cnb1 or crz1 mutants exhibit irregular plasma membranes at 37
• C (Fig. 3) .
Although the targets of calcineurin (such as PMC1 or RCN2) have been identified in C. albicans, C. dubliniensis and C. glabrata, these targets are transcriptionally regulated and their respective mutants are not critical to hyphal development or other stress conditions, thus they cannot represent the functional targets of calcineurin. In the future, it will be necessary to identify functional substrates (in addition to Crz1) of calcineurin involved in hyphal or pseudohyphal growth of Candida species.
Role of calcineurin in the pathogenesis of Candida species
It is evident that calcineurin is critical for virulence in Candida species, but the associated mechanisms for successful infection might vary among Candida species as highlighted by the results obtained from a murine systemic infection model. In three closely related Candida species (i.e. C. albicans, C. dubliniensis and C. tropicalis), the growth defects in calcineurin mutants in serum contributed to attenuated virulence (Blankenship et al. 2003; Chen et al. , 2014 , whereas the growth defects in C. glabrata calcineurin mutants at body temperature (37
• C) demonstrated a unique case of reduced virulence in a murine systemic infection model (Table 1 and Fig. 2 ). The necessity for calcineurin for survival at 37
• C was first found in a Candida species in C. glabrata, and is similar to the role of calcineurin in the basidiomycetes Cryptococcus neoformans and Cr. gattii, suggesting convergent evolution of calcineurin signaling in thermotolerance and virulence in C. glabrata and Cryptococcus species (Odom et al. 1997; Chen et al. 2013 ). An additional explanation of the attenuated virulence of C. glabrata calcineurin mutants may be the defects in their plasma membrane ).
In addition to the murine systemic infection model, ocular and urinary infections were used to determine whether calcineurin signaling plays niche specific roles in Candida species. Our recent studies demonstrated that C. albicans Opi1, a negative regulator of INO1 expression and inositol biosynthesis in S. cerevisiae and C. glabrata, is required for virulence in vaginal infection but not in a murine systemic infection model, indicating that Opi1 has a niche specific role (Chen et al. 2015) . Meanwhile, C. albicans Opi1 does not play roles in regulating CaINO1 expression and inositol biosynthesis, suggesting that Opi1 has a different function in C. albicans compared to C. glabrata or S. cerevisiae (Bethea et al. 2010; Chen et al. 2015) . Previous studies of calcineurin roles in murine ocular infections found that the function of calcineurin in controlling virulence in this model is conserved in C. albicans, C. dubliniensis, C. tropicalis, C. lusitaniae Figure 3 . Calcineurin is required for hyphal growth or plasma membrane integrity in Candida species. Calcineurin mutants exhibit reduced hyphal growth in a rat denture biofilm model (C. dubliniensis), serum agar medium (C. tropicalis) and V8 medium (C. lusitaniae). Candida glabrata calcineurin mutant showed defects in plasma membrane integrity in YPD medium. Scanning electron microscopy is used for C. dubliniensis, C. tropicalis and C. lusitaniae, while transmission electron microscopy is adapted for C. glabrata. Scale bars are 5 μm in C. dubliniensis, C. tropicalis and C. lusitaniae, and 100 nm in C. glabrata. and C. glabrata (Onyewu, Afshari and Heitman 2006; Chen et al. 2012 Chen et al. , 2014 Chen et al. , 2015 . In addition, C. glabrata calcineurin was found to be critical for establishing urinary tract infection . However, this urinary tract infection model has not been used for determining roles of calcineurin in other Candida species.
In contrast to the conserved function of calcineurin in virulence, the downstream substrate of calcineurin, Crz1, plays calcineurin-dependent or independent roles in multiple murine infection models of Candida species (Table 1 and Fig. 2 ). For instance, C. dubliniensis and C. tropicalis crz1/crz1 mutants, like their calcineurin mutants, exhibited attenuated virulence in a murine systemic infection model, but showed wild-type virulence in ocular infection models (Chen et al. , 2014 (Table 1 and Fig. 2) . These results suggest that calcineurin might have targets other than Crz1 to control pathogenesis during ocular infection of C. dubliniensis and C. tropicalis. Interestingly, in C. lusitaniae and C. glabrata, the crz1 mutants exhibited calcineurin dependence in the control of virulence in murine systemic and ocular infection models ). These findings demonstrate the divergent functions of Crz1 in ocular infection among Candida species.
In addition to playing a key role in the pathogenesis of Candida species, calcineurin is required for virulence in other fungal pathogens such as Cr. neoformans, Cr. gattii and Aspergillus fumigatus (Odom et al. 1997; Steinbach et al. 2006; Chen et al. 2013) (Fig. 1) , suggesting calcineurin controls the virulence of multiple human fungal pathogens. Unlike the diverse roles of Crz1 in virulence of Candida species, the Crz1 (also called SP1 or CrzA) from Cr. neoformans or A. fumigatus is required for pathogenicity in animal infection models (Cramer et al. 2008; Soriani et al. 2008; Adler et al. 2011) (Fig. 1) , indicating the variant roles of Crz1 in pathogenicity in human fungal pathogens.
Calcineurin control of antifungal drug tolerance
Currently, there are few antifungal drugs on the market, but opportunities for antifungal drug development exist (Barnes et al. 2014; Denning and Bromley 2015) . Based on our previous studies, it is clear that calcineurin is required for drug tolerance of azoles such as fluconazole (FLC), posaconazole (PSC) or voriconazole (VRC), and echinocandins such as caspofungin (CSF), micafungin (MCF) or anidulafungin (ANF), but not amphotericin B in Candida species (Table 1 and Fig. 2 ). The necessity for calcineurin in virulence and drug tolerance makes it an attractive drug target. Currently used calcineurin inhibitors FK506 and cyclosporin A have immunosuppressive activity and are not suitable for immediate use as antifungal drugs. The development of FK506 or cyclosporin A analogs that are non-or less toxic to humans, but that maintain their strong activity against fungal pathogens hold promise as a new class of antifungal drugs that target signal transduction.
Interestingly, the functions of Crz1 in drug tolerance are different across Candida species. For example, C. albicans and C. dubliniensis crz1/crz1 mutants exhibited susceptibility to azoles (FLC, PSC and VRC) at a level between the wild-type and calcineurin mutants ), but C. tropicalis crz1/crz1 mutants showed susceptibility similar to the wild type (Chen et al. 2014) (Table 1 ). The mechanisms of the function of Crz1 in C. albicans, C. dubliniensis and C. tropicalis remain unclear. Surprisingly, C. lusitaniae and C. glabrata crz1 mutants exhibited resistance to azoles (FLC, PSC and VRC) , which is in contrast to the azole susceptibility of calcineurin mutants in C. albicans and C. dubliniensis. Based on these findings, it was suggested that Crz1 is a negative regulator of azole tolerance in C. lusitaniae and C. glabrata, but not in the phylogenetically distant C. albicans, C. dubliniensis or C. tropicalis. In echinocandin tolerance, Crz1 has been found to play a minor role, but some of the findings are of interest. For instance, crz1 mutants exhibited susceptibility to CSF and ANF in C. glabrata, but not in other Candida species (Table 1) . Although most crz1/crz1 or crz1 mutants of Candida species did not show susceptibility to CSF and ANF, these crz1 mutants were susceptible to MCF (except C. lusitaniae) (Table 1) . MCF, CSF and ANF share similar chemical structures and have common properties (Eschenauer, Depestel and Carver 2007; Chen, Slavin and Sorrell 2011) , but their different responses to crz1/crz1 or crz1mutants suggest novel mechanisms for echinocandins. Further comparison and investigation of the differences between CSF, MCF and ANF will be required.
CONCLUSIONS
In this minireview, we summarized the conserved and divergent functions of calcineurin and Crz1 in growth, morphogenesis and virulence of Candida species. Calcineurin function is conserved in virulence and drug tolerance in five Candida species, suggesting calcineurin can be a drug target and its inhibitor (FK506 or cyclosporin A) combined with current antifungal drugs. The present approach used to develop calcineurin inhibitors is to modify the chemical structure of FK506 or cyclosporin A in order to reduce immunosuppression activity but maintain strong antifungal activity. In addition to conserved functions in virulence and drug tolerance of Candida species, C. glabrata calcineurin has a divergent function in controlling thermotolerance, indicating a novel mechanism of calcineurin in C. glabrata that establishes infection. Further characterization of the mechanisms involved in the thermotolerance of C. glabrata calcineurin will add to basic studies in the field. 
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